Author:
Wu Yuchen,Sun Xuefei,Liu Jing,Qian Jun,Bai Xueyan,Chen Yuedan,Liu Yuanbo
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology,Surgery
Reference19 articles.
1. Wang CC, Carnevale J, Rubenstein JL. Progress in central nervous system lymphomas[J]. Br J Haematol. 2014;166:311–25.
2. Ferreri AJ, Reni M, Foppoli M, et al. High-dose cytarabine plushigh-dose methotrexate versus high-dose methotrexate alone inpatients with primary CNS lymphoma: a randomised phase 2 trial. Lancet. 2009;374:1512–20.
3. Xuefei S, Jin L, Shengju S, et al. Efficacy of rituximab combined with chemotherapy regimen for the treatment of primary centralnervous system lymphomas. Chin J Neurosurg. 2016;32:388–92.
4. Montero AJ, McCarthy JJ, Chen G, Rice L. Acute respiratory distress syndrome after rituximab infusion. Int J Hematol. 2005;82:324–6.
5. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235–42.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献